IPO queue upswelling: Data Byte

With two biopharmas already trading on NASDAQ following their IPOs this month, the queue of companies seeking public listings has begun to swell.

Seven therapeutics developers filed for offerings late Friday, ready to test investors’ appetite anew following a record-setting year for IPOs. ...